首页>投融资

Antiva Biosciences

E轮

Antiva Biosciences is focused on the research, development and commercialization of localized antivirals for infections with human papillomavirus (HPV).In April 2023, Antiva Biosciences closed a $53 million Series E equity financing.In November 2021, Antiva Biosciences closed a $31 million Series D equity financing.In July 2018, the company raised $15 million in Series C-1 financing.In March 2017, the company raised $22 million in a Series C financing round.In August 2015, the company raised $16 million through a series B financing

http://www.antivabio.com/

470007

基本信息

公司全称

Antiva Biosciences Inc
类型

生物制药公司
产业领域

药品研发/制造、生物药
公司人数

不明确
地址

280 OLD COUNTY ROAD #257 BRISBANE CALIFORNIA 94005; US; Telephone: +16508221400;
联系电话

(650)822-1400
邮箱

info@antivabio.com
成立时间

投融资

2023-04-27

E轮

5300万美元

GV

BioImpact Capital

Canaan Partners

Sofinnova Partners

Adjuvant Capital

Lumira Ventures
2021-11-02

D轮

3100万美元

Gaingels

Alexandria Venture Investments

GV

Canaan Partners

HBM Healthcare

Dong-A ST

Mana Ventures

Avestria Ventures

Adjuvant Capital

Osage University Partners

Brace Pharma Capital

Lumira Ventures

Sirona Capital

Sofinnova Partners
2018-07-11

C轮(C2)

1500万美元

Canaan Partners

Osage University Partners

Brace Pharma Capital

Sirona Capital

Lumira Capital

Sofinnova Partners
2017-03-30

C轮(C1)

2200万美元

Alexandria Venture Investments

Canaan Partners

Osage University Partners

Brace Pharma Capital

Timefolio Capital

Sofinnova Partners
2015-08-01

B轮

1600万美元

Canaan Partners

Sofinnova Partners
2014-12-23

A轮

175万美元

未透露
2014-07-10

债权融资

110万美元

未透露
2013-06-12

天使轮

51.101万美元

未透露
加载更多

Antiva Biosciences

基本信息

投融资

相关投融资企业